• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型 E3 连接酶 SCF 对非磷酸化 c-myc 的泛素化作用。

Ubiquitylation of unphosphorylated c-myc by novel E3 ligase SCF.

机构信息

Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.

Department of Biochemistry and Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.

出版信息

Cancer Biol Ther. 2022 Dec 31;23(1):348-357. doi: 10.1080/15384047.2022.2061279.

DOI:10.1080/15384047.2022.2061279
PMID:35438057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9037475/
Abstract

Overexpression of c-myc via increased transcription or decreased protein degradation is common to many cancer etiologies. c-myc protein degradation is mediated by ubiquitin-dependent degradation, and this ubiquitylation is regulated by several E3 ligases. The primary regulator is Fbxw7, which binds to a phospho-degron within c-myc. Here, we identify a new E3 ligase for c-myc, Fbxl8 (F-box and Leucine Rich Repeat Protein 8), as an adaptor component of the SCF (Skp1-Cullin1-F-box protein) ubiquitin ligase complex, for selective c-myc degradation. SCF binds and ubiquitylates c-myc, independent of phosphorylation, revealing that it regulates a pool of c-myc distinct from SCF. Loss of Fbxl8 increases c-myc protein levels, protein stability, and cell division, while overexpression of Fbxl8 reduces c-myc protein levels. Concurrent loss of Fbxl8 and Fbxw7 triggers a robust increase in c-myc protein levels consistent with targeting distinct pools of c-myc. This work highlights new mechanisms regulating c-myc degradation.

摘要

c-myc 的过度表达通过转录增加或蛋白质降解减少是许多癌症病因的共同特征。c-myc 蛋白降解是由泛素依赖性降解介导的,这种泛素化受几种 E3 连接酶调节。主要调节剂是 Fbxw7,它与 c-myc 内的磷酸化降解结构域结合。在这里,我们确定了一种新的 c-myc E3 连接酶 Fbxl8(F-box 和亮氨酸丰富重复蛋白 8),作为 SCF(Skp1-Cullin1-F-box 蛋白)泛素连接酶复合物的衔接子组件,用于选择性降解 c-myc。SCF 结合并泛素化 c-myc,与磷酸化无关,表明它调节了与 SCF 不同的 c-myc 池。Fbxl8 的缺失增加了 c-myc 的蛋白水平、蛋白质稳定性和细胞分裂,而过表达 Fbxl8 则降低了 c-myc 的蛋白水平。同时缺失 Fbxl8 和 Fbxw7 会导致 c-myc 蛋白水平显著增加,这与靶向不同的 c-myc 池一致。这项工作强调了调节 c-myc 降解的新机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d0a/9037475/75fa80924cd2/KCBT_A_2061279_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d0a/9037475/a91519c9f0fa/KCBT_A_2061279_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d0a/9037475/e2e7578ebfcf/KCBT_A_2061279_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d0a/9037475/9afa4888d58c/KCBT_A_2061279_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d0a/9037475/05b870daaa0f/KCBT_A_2061279_F0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d0a/9037475/164834f33562/KCBT_A_2061279_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d0a/9037475/75fa80924cd2/KCBT_A_2061279_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d0a/9037475/a91519c9f0fa/KCBT_A_2061279_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d0a/9037475/e2e7578ebfcf/KCBT_A_2061279_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d0a/9037475/9afa4888d58c/KCBT_A_2061279_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d0a/9037475/05b870daaa0f/KCBT_A_2061279_F0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d0a/9037475/164834f33562/KCBT_A_2061279_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d0a/9037475/75fa80924cd2/KCBT_A_2061279_F0006_OC.jpg

相似文献

1
Ubiquitylation of unphosphorylated c-myc by novel E3 ligase SCF.新型 E3 连接酶 SCF 对非磷酸化 c-myc 的泛素化作用。
Cancer Biol Ther. 2022 Dec 31;23(1):348-357. doi: 10.1080/15384047.2022.2061279.
2
The F-box protein FBXL16 up-regulates the stability of C-MYC oncoprotein by antagonizing the activity of the F-box protein FBW7.F-box 蛋白 FBXL16 通过拮抗 F-box 蛋白 FBW7 的活性来上调 C-MYC 癌蛋白的稳定性。
J Biol Chem. 2020 Jun 5;295(23):7970-7980. doi: 10.1074/jbc.RA120.012658. Epub 2020 Apr 28.
3
Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.Fbw7通过泛素依赖性降解对GATA结合蛋白2水平的调控:细胞周期蛋白B-细胞周期蛋白依赖性激酶1介导的GATA结合蛋白2中苏氨酸176磷酸化的参与
J Biol Chem. 2015 Apr 17;290(16):10368-81. doi: 10.1074/jbc.M114.613018. Epub 2015 Feb 10.
4
Physiological Functions of FBW7 in Metabolism.FBW7 在新陈代谢中的生理功能。
Horm Metab Res. 2022 May;54(5):280-287. doi: 10.1055/a-1816-8903. Epub 2022 May 9.
5
Isoform-specific SCF(Fbw7) ubiquitination mediates differential regulation of PGC-1α.亚型特异性SCF(Fbw7)泛素化介导PGC-1α的差异调节。
J Cell Physiol. 2015 Apr;230(4):842-52. doi: 10.1002/jcp.24812.
6
Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.SKP1-CUL1-F-box 蛋白(SCF)E3 泛素连接酶在皮肤癌中的作用。
J Genet Genomics. 2013 Mar 20;40(3):97-106. doi: 10.1016/j.jgg.2013.02.001. Epub 2013 Feb 10.
7
Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase.腺病毒E1A抑制SCF(Fbw7)泛素连接酶。
J Biol Chem. 2009 Oct 9;284(41):27766-27779. doi: 10.1074/jbc.M109.006809. Epub 2009 Aug 13.
8
The Role of FBXW7 in Gynecologic Malignancies.FBXW7 在妇科恶性肿瘤中的作用。
Cells. 2023 May 17;12(10):1415. doi: 10.3390/cells12101415.
9
CRL2 and CRL1 cooperatively mediate c-Myc degradation.CRL2 和 CRL1 协同介导 c-Myc 降解。
Oncogene. 2024 Jun;43(25):1917-1929. doi: 10.1038/s41388-024-03048-7. Epub 2024 May 2.
10
A Novel Signature of CCNF-Associated E3 Ligases Collaborate and Counter Each Other in Breast Cancer.CCNF相关E3连接酶的一种新型特征在乳腺癌中相互协作与对抗。
Cancers (Basel). 2021 Jun 8;13(12):2873. doi: 10.3390/cancers13122873.

引用本文的文献

1
Key roles of ubiquitination in regulating critical regulators of cancer stem cell functionality.泛素化在调节癌症干细胞功能的关键调节因子中的关键作用。
Genes Dis. 2024 Apr 17;12(3):101311. doi: 10.1016/j.gendis.2024.101311. eCollection 2025 May.
2
Targeted variant prevalence of FBXW7 gene mutation in colorectal carcinoma propagation. The first systematic review and meta-analysis.结直肠癌增殖中FBXW7基因突变的靶向变异患病率。首个系统评价与Meta分析。
Heliyon. 2024 May 22;10(11):e31471. doi: 10.1016/j.heliyon.2024.e31471. eCollection 2024 Jun 15.
3
SCF-FBXL8 contributes to liver metastasis and stem-cell-like features in colorectal cancer cells by mediating ubiquitination and degradation of TP53.

本文引用的文献

1
UALCAN: An update to the integrated cancer data analysis platform.UALCAN:一个集成癌症数据分析平台的更新。
Neoplasia. 2022 Mar;25:18-27. doi: 10.1016/j.neo.2022.01.001. Epub 2022 Jan 22.
2
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc.去除癌症中的 Myc:直接抑制 c-Myc 的治疗策略。
Mol Cancer. 2021 Jan 4;20(1):3. doi: 10.1186/s12943-020-01291-6.
3
Fbxl8 suppresses lymphoma growth and hematopoietic transformation through degradation of cyclin D3.Fbxl8 通过降解细胞周期蛋白 D3 抑制淋巴瘤生长和造血转化。
SCF-FBXL8 通过介导 TP53 的泛素化和降解促进结直肠癌细胞的肝转移和干细胞样特征。
Clin Transl Med. 2023 Mar;13(3):e1208. doi: 10.1002/ctm2.1208.
Oncogene. 2021 Jan;40(2):292-306. doi: 10.1038/s41388-020-01532-4. Epub 2020 Oct 29.
4
MYC and the unfolded protein response in cancer: synthetic lethal partners in crime?MYC 与癌症中的未折叠蛋白反应:协同犯罪的合成致死伙伴?
EMBO Mol Med. 2020 May 8;12(5):e11845. doi: 10.15252/emmm.201911845. Epub 2020 Apr 20.
5
OSdlbcl: An online consensus survival analysis web server based on gene expression profiles of diffuse large B-cell lymphoma.OSdlbcl:一个基于弥漫性大 B 细胞淋巴瘤基因表达谱的在线共识生存分析网络服务器。
Cancer Med. 2020 Mar;9(5):1790-1797. doi: 10.1002/cam4.2829. Epub 2020 Jan 9.
6
MYC Deregulation in Primary Human Cancers.原发性人类癌症中的MYC失调
Genes (Basel). 2017 May 25;8(6):151. doi: 10.3390/genes8060151.
7
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.GEPIA:一个用于癌症和正常基因表达谱分析及交互式分析的网络服务器。
Nucleic Acids Res. 2017 Jul 3;45(W1):W98-W102. doi: 10.1093/nar/gkx247.
8
MYC is a critical target of FBXW7.MYC是FBXW7的关键靶点。
Oncotarget. 2015 Feb 20;6(5):3292-305. doi: 10.18632/oncotarget.3203.
9
MYC and the control of apoptosis.MYC与细胞凋亡的调控
Cold Spring Harb Perspect Med. 2014 Jul 1;4(7):a014407. doi: 10.1101/cshperspect.a014407.
10
MYC degradation.MYC 降解。
Cold Spring Harb Perspect Med. 2014 Mar 1;4(3):a014365. doi: 10.1101/cshperspect.a014365.